Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 257 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2919 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2017-08-01 2018-05-11 17844
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2019-09-26 2019-10-04 94825
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-01-28 2021-04-08 132672
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-05-06 2021-06-10 138904
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-06-24 2021-07-15 141463
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-08-27 2021-09-23 144726
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-09-16 2022-04-21 145780
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2022-06-09 2022-06-17 162283
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2022-12-01 2022-12-15 176776
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2024-09-05 2024-09-19 236802
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2024-12-13 2025-03-13 245601
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-01-16 2025-02-13 247885
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-03-06 2025-04-24 252075
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-03-27 2025-04-10 253568
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2025-05-08 2025-10-02 256917
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Actual shortage 2025-10-23 2025-11-27 270218
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Actual shortage 2025-10-30 2025-11-27 270660
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2021-10-21 2021-12-17 147699
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2022-08-18 2022-12-22 167237
TEVA-ABACAVIR/LAMIVUDINE 300MG 600MG TABLET Resolved 2023-06-08 2023-07-05 194180

Showing 641 to 660 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RASAGILINE 1MG TABLET Reversed 2025-05-28 2025-06-04 258753
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-04-29 2025-04-29 256079
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258473
TEVA-RISPERIDONE 1MG TABLET Reversed 2025-05-28 2025-06-04 258673
TEVA-RISPERIDONE 2MG TABLET Reversed 2025-05-28 2025-06-04 258679
TEVA-RISPERIDONE 3MG TABLET Reversed 2025-05-28 2025-06-04 258685
TEVA-RISPERIDONE 4MG TABLET Reversed 2025-05-28 2025-06-04 258688
TEVA-RISPERIDONE 0.25MG TABLET Reversed 2025-05-28 2025-06-04 258711
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-ROSUVASTATIN 20MG TABLET Reversed 2025-05-28 2025-06-04 258765
TEVA-SPIRONOLACTONE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258486
TEVA-SUCRALFATE 1G TABLET Discontinued 2025-09-02 2025-09-02 266359
TEVA-TECNAL 50MG 330MG 40MG TABLET Discontinued 2025-05-28 2025-05-28 258471
TEVA-TECNAL 330MG 40MG 50MG CAPSULE Discontinued 2025-05-28 2025-05-28 258478
TEVA-TECNAL C 1/2 50MG 330MG 30MG 40MG CAPSULE Discontinued 2025-05-28 2025-05-28 258462

Showing 361 to 380 of 435